Patricia Carr - Nov 18, 2025 Form 4 Insider Report for Jazz Pharmaceuticals plc (JAZZ)

Role
SVP, Chief Accounting Officer
Signature
By: /s/Adam Guttmann, as attorney in fact For: Patricia Carr
Stock symbol
JAZZ
Transactions as of
Nov 18, 2025
Transactions value $
-$253,457
Form type
4
Date filed
11/20/2025, 06:13 PM
Previous filing
Mar 11, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Carr Patricia SVP, Chief Accounting Officer 5TH FL, WATERLOO EXCHANGE, WATERLOO RD, DUBLIN 4, IRELAND By: /s/Adam Guttmann, as attorney in fact For: Patricia Carr 2025-11-20 0001784606

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JAZZ Ordinary Shares Sale -$12.5K -69 -0.97% $181.66 7.01K Nov 18, 2025 Direct F1
transaction JAZZ Ordinary Shares Options Exercise $715K +5.25K +74.87% $136.18 12.3K Nov 18, 2025 Direct
transaction JAZZ Ordinary Shares Sale -$956K -5.25K -42.82% $182.07 7.01K Nov 18, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JAZZ Non-Qualified Stock Option (right to buy) Options Exercise $0 -5.25K -100% $0.00 0 Nov 18, 2025 Ordinary Shares 5.25K $136.18 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person acquired 69 ordinary shares under a Section 423 Employee Stock Purchase Plan on May 30, 2025.
F2 These options were granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the grant date, March 2, 2017, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter. The option was fully vested as of March 2, 2021.